Vault-13

AJU IB Investment Co., Ltd.

Seoul, M5 · CIK 1710065 · 13F filing filed 2025-07-10

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$91.9m reported value +9.3% vs Q1 2025
8positions
100.0%in top 10
0 new 0 added 1 reduced 0 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARCELLX INC COMMON STOCK ACLX ACLX 1,047,557 $69.0m75.07% 75.07% UnchangedShares held: Q3 2024 —, Q4 2024 1.0m, Q1 2025 1.0m, Q2 2025 1.0m
2 KYMERA THERAPEUTICS INC COM KYMR KYMR 457,059 $19.9m21.71% 21.71% UnchangedShares held: Q3 2024 —, Q4 2024 457.1k, Q1 2025 457.1k, Q2 2025 457.1k
3 SEER INC COM CL A SEER SEER 816,375 $1.7m1.90% 1.90% UnchangedShares held: Q3 2024 —, Q4 2024 816.4k, Q1 2025 816.4k, Q2 2025 816.4k
4 XILIO THERAPEUTICS INC COM COM 667,742 $454.0k0.49% 0.49% UnchangedShares held: Q3 2024 —, Q4 2024 667.7k, Q1 2025 667.7k, Q2 2025 667.7k
5 CARISMA THERAPEUTICS INC COM CARM CARM 718,332 $281.3k0.31% 0.31% UnchangedShares held: Q3 2024 —, Q4 2024 718.3k, Q1 2025 718.3k, Q2 2025 718.3k
6 RALLYBIO CORP COM COM 754,678 $255.1k0.28% 0.28% UnchangedShares held: Q3 2024 —, Q4 2024 754.7k, Q1 2025 754.7k, Q2 2025 754.7k
7 SUTRO BIOPHARMA INC COM COM 175,000 $124.9k0.14% 0.14% UnchangedShares held: Q3 2024 —, Q4 2024 175.0k, Q1 2025 175.0k, Q2 2025 175.0k
8 RAPT THERAPEUTICS INC COM COM 12,437 $99.5k0.11% 0.11% ReducedShares held: Q3 2024 —, Q4 2024 99.5k, Q1 2025 99.5k, Q2 2025 12.4k -87.1k -87,066 -87.5%